AIM IMMUNOTECH INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$6M
↓-32.8% -$3Mvs FY2024
Total Liabilities
$16M
↑+56.7% +$6Mvs FY2024
Cash
$3M
↑+75.5% +$1Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $6M | $9M |
| Current Assets | $3M | $4M |
| Cash | $3M | $2M |
| ST Investments | $62K | $2M |
| Receivables | $7K | $0 |
| Inventory | $0 | $0 |
| Other Current | $241K | $199K |
| Non-Current Assets | $2M | $4M |
| PPE | $71K | $108K |
| Goodwill | $0 | $0 |
| Intangibles | $2M | $3M |
| Investments | $0 | $0 |
| Other Non-Current | $755K | $2M |
| Total Liab+Eq | $6M | $9M |
| Current Liab. | $6M | $10M |
| Accounts Payable | $2M | $6M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $5M | $3M |
| Non-Current Liab. | $9M | $395K |
| Long-Term Debt | $4M | $3M |
| Other LT Liab. | $5M | $0 |
| Equity | $-10M | $-1M |
| Retained Earnings | $441M | $427M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · AIM · Comparing FY2025 vs FY2024